Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Total Long-Term Liabilities : ¥95 Mil (As of Sep. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Zhejiang Hisoar Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Sep. 2024 was ¥95 Mil.

Zhejiang Hisoar Pharmaceutical Co Total Long-Term Liabilities Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Total Long-Term Liabilities Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Long-Term Liabilities

Get a 7-Day Free Trial

82.45

166.79

173.63

317.51

111.54

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Long-Term Liabilities	Get a 7-Day Free Trial															187.33	111.54	216.95	148.98	95.34

Zhejiang Hisoar Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Zhejiang Hisoar Pharmaceutical Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Hisoar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Total Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000

Website

http://www.hisoar.com

Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.

Executives

Wang Yang Chao	Director
Yang Si Wei	Directors, executives
Xu Guo Rui	Executives
Xu Hua Qing	Secretary Dong
Hong Ming	Director
Guo Min Long	Director
Li Hong Ming	Executives
Jiang Ru Dong	Securities Affairs Representative
Mao Wen Hua	Executives
Sun Yang	Director
Li Wei Jin	Director
Luo Yu Hong	Director
Pan Qing Hua	Directors, executives
Chen Zheng Hua	Supervisors
Jia Qiang	Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines